ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis
NCT ID: NCT04522310
Last Updated: 2021-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
183 participants
OBSERVATIONAL
2020-07-07
2021-05-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection
NCT04357847
Proadrenomedullin and Microcirculation in Monitoring Organ Dysfunction in Patient With Infection
NCT03931967
Is Bio-adrenomedullin (Bio-ADM) a Prognostic Factor in Patients With COVID-19 Treated in the ICU?
NCT04813939
Hemoperfusion in Critical Patients With Septic Multiorgan Dysfunction Syndrome.
NCT05044403
Adrenomedullin and Outcome in Severe Sepsis and Septic Shock
NCT02393781
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MR-Pro-ADM
Dosage of MR-pro-ADM
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Legal reasons (patients under guardianship, curatorship)
* Patient's refusal
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier de Lens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital of Arras
Arras, , France
Hospital of Boulogne/mer
Boulogne-sur-Mer, , France
Hospital of DOUAI
Douai, , France
Hospital of Dunkerque
Dunkirk, , France
Hospital Dr Schaffner
Lens, , France
Hospital of Roubaix
Roubaix, , France
Hospital of Tourcoing
Tourcoing, , France
Hospitalier of Valenciennes
Valenciennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.